Skip to content
10-K/A

Annual Report

Karuna Therapeutics, Inc.

0000950170-24-031505

← back to feed
Filed
Mar 14, 2024 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Mar 12, 2024 38.2M sh